Press

Featured In

Circle Pharma
October 15, 2024

Circle Pharma Announces First Patients Dosed in Phase 1 Clinical Trial of First-in-Class Oral Cyclin A/B RxL Inhibitor CID-078 for Advanced Solid Tumors

Featured In

RTE News
October 14, 2024

New Clinical Trial Unit Opens for Irish Cancer Patients

Featured In

Irish Independent
October 14, 2024

‘I Had No Lesions On My Skin. It Happens in 5pc of Cases’ – Dublin Woman Reached Stage Four Cancer Before Getting Access to Therapy

Featured In

Irish Times
October 14, 2024

‘A Day of Hope’: Irish Hospital Patients Get Access to ‘Early Phase’ Cancer Drugs

Featured In

BusinessWire
October 8, 2024

First Patient Dosed with NILK-2401 in Phase I Clinical Trial

Featured In

Applied Clinical Trials
September 18, 2024

DPharm 2024: Problem Solving in the Clinical Trial Realm